Annual ROE
-73.67%
+22.41%+23.32%
December 31, 2023
Summary
- As of February 7, 2025, LYRA annual return on equity is -73.67%, with the most recent change of +22.41% (+23.32%) on December 31, 2023.
- During the last 3 years, LYRA annual ROE has fallen by -43.97% (-148.05%).
- LYRA annual ROE is now -657.26% below its all-time high of 13.22%, reached on December 31, 2019.
Performance
LYRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-161.20%
-28.04%-21.06%
September 30, 2024
Summary
- As of February 7, 2025, LYRA quarterly return on equity is -161.20%, with the most recent change of -28.04% (-21.06%) on September 30, 2024.
- Over the past year, LYRA quarterly ROE has dropped by -88.18% (-120.76%).
- LYRA quarterly ROE is now -270.62% below its all-time high of 94.48%, reached on September 30, 2020.
Performance
LYRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LYRA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.3% | -120.8% |
| 3 y3 years | -148.1% | -120.8% |
| 5 y5 years | -1408.5% | -120.8% |
LYRA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.3% | -138.1% | at low |
| 5 y | 5-year | -657.3% | +23.3% | -270.6% | at low |
| alltime | all time | -657.3% | +23.3% | -270.6% | at low |
Lyra Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -161.20%(+21.1%) |
| Jun 2024 | - | -133.16%(+60.8%) |
| Mar 2024 | - | -82.82%(+10.8%) |
| Dec 2023 | -73.67%(-23.3%) | -74.78%(+2.4%) |
| Sep 2023 | - | -73.02%(+7.9%) |
| Jun 2023 | - | -67.69%(-13.9%) |
| Mar 2023 | - | -78.60%(-1.2%) |
| Dec 2022 | -96.08% | -79.54%(-8.6%) |
| Sep 2022 | - | -87.06%(-4.9%) |
| Jun 2022 | - | -91.57%(-19.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -113.96%(+35.2%) |
| Dec 2021 | -79.98%(+169.3%) | -84.26%(+40.8%) |
| Sep 2021 | - | -59.85%(+30.3%) |
| Jun 2021 | - | -45.92%(+38.4%) |
| Mar 2021 | - | -33.18%(-56.7%) |
| Dec 2020 | -29.70%(-324.7%) | -76.66%(-181.1%) |
| Sep 2020 | - | 94.48%(+197.5%) |
| Jun 2020 | - | 31.76%(+134.4%) |
| Mar 2020 | - | 13.55%(+2.5%) |
| Dec 2019 | 13.22%(+134.8%) | 13.22% |
| Dec 2018 | 5.63% | - |
FAQ
- What is Lyra Therapeutics annual return on equity?
- What is the all time high annual ROE for Lyra Therapeutics?
- What is Lyra Therapeutics annual ROE year-on-year change?
- What is Lyra Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Lyra Therapeutics?
- What is Lyra Therapeutics quarterly ROE year-on-year change?
What is Lyra Therapeutics annual return on equity?
The current annual ROE of LYRA is -73.67%
What is the all time high annual ROE for Lyra Therapeutics?
Lyra Therapeutics all-time high annual return on equity is 13.22%
What is Lyra Therapeutics annual ROE year-on-year change?
Over the past year, LYRA annual return on equity has changed by +22.41% (+23.32%)
What is Lyra Therapeutics quarterly return on equity?
The current quarterly ROE of LYRA is -161.20%
What is the all time high quarterly ROE for Lyra Therapeutics?
Lyra Therapeutics all-time high quarterly return on equity is 94.48%
What is Lyra Therapeutics quarterly ROE year-on-year change?
Over the past year, LYRA quarterly return on equity has changed by -88.18% (-120.76%)